These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28400153)

  • 41. A decision support framework for genomically informed investigational cancer therapy.
    Meric-Bernstam F; Johnson A; Holla V; Bailey AM; Brusco L; Chen K; Routbort M; Patel KP; Zeng J; Kopetz S; Davies MA; Piha-Paul SA; Hong DS; Eterovic AK; Tsimberidou AM; Broaddus R; Bernstam EV; Shaw KR; Mendelsohn J; Mills GB
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25863335
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cancer classification in the genomic era: five contemporary problems.
    Song Q; Merajver SD; Li JZ
    Hum Genomics; 2015 Oct; 9():27. PubMed ID: 26481255
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Precision oncology based on omics data: The NCT Heidelberg experience.
    Horak P; Klink B; Heining C; Gröschel S; Hutter B; Fröhlich M; Uhrig S; Hübschmann D; Schlesner M; Eils R; Richter D; Pfütze K; Geörg C; Meißburger B; Wolf S; Schulz A; Penzel R; Herpel E; Kirchner M; Lier A; Endris V; Singer S; Schirmacher P; Weichert W; Stenzinger A; Schlenk RF; Schröck E; Brors B; von Kalle C; Glimm H; Fröhling S
    Int J Cancer; 2017 Sep; 141(5):877-886. PubMed ID: 28597939
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Implementing precision medicine initiatives in the clinic: a new paradigm in drug development.
    Hollebecque A; Massard C; Soria JC
    Curr Opin Oncol; 2014 May; 26(3):340-6. PubMed ID: 24709975
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Towards Precision Medicine in the Clinic: From Biomarker Discovery to Novel Therapeutics.
    Collins DC; Sundar R; Lim JSJ; Yap TA
    Trends Pharmacol Sci; 2017 Jan; 38(1):25-40. PubMed ID: 27871777
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Using biointelligence to search the cancer genome: an epistemological perspective on knowledge recovery strategies to enable precision medical genomics.
    Mousses S; Kiefer J; Von Hoff D; Trent J
    Oncogene; 2008 Dec; 27 Suppl 2():S58-66. PubMed ID: 19956181
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine.
    Hiley C; de Bruin EC; McGranahan N; Swanton C
    Genome Biol; 2014 Aug; 15(8):453. PubMed ID: 25222836
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumour heterogeneity and drug resistance: personalising cancer medicine through functional genomics.
    Lee AJ; Swanton C
    Biochem Pharmacol; 2012 Apr; 83(8):1013-20. PubMed ID: 22192819
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Next-Generation Sequencing and Applications to the Diagnosis and Treatment of Lung Cancer.
    Kruglyak KM; Lin E; Ong FS
    Adv Exp Med Biol; 2016; 890():123-36. PubMed ID: 26703802
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents.
    Gao Q; Wang ZC; Duan M; Lin YH; Zhou XY; Worthley DL; Wang XY; Niu G; Xia Y; Deng M; Liu LZ; Shi JY; Yang LX; Zhang S; Ding ZB; Zhou J; Liang CM; Cao Y; Xiong L; Xi R; Shi YY; Fan J
    Gastroenterology; 2017 Jan; 152(1):232-242.e4. PubMed ID: 27639803
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Precision medicine for metastatic breast cancer--limitations and solutions.
    Arnedos M; Vicier C; Loi S; Lefebvre C; Michiels S; Bonnefoi H; Andre F
    Nat Rev Clin Oncol; 2015 Dec; 12(12):693-704. PubMed ID: 26196250
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Translating cancer genomes and transcriptomes for precision oncology.
    Roychowdhury S; Chinnaiyan AM
    CA Cancer J Clin; 2016; 66(1):75-88. PubMed ID: 26528881
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
    Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
    JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cancer genomics guide clinical practice in personalized medicine.
    Lehmann-Che J; Poirot B; Boyer JC; Evrard A
    Therapie; 2017 Sep; 72(4):439-451. PubMed ID: 28258721
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Genome sequencing and personalized medicine: perspectives and limitations].
    Le Gall JY; Debré P;
    Bull Acad Natl Med; 2014 Jan; 198(1):101-17. PubMed ID: 26259290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The translational potential of circulating tumour DNA in oncology.
    Patel KM; Tsui DW
    Clin Biochem; 2015 Oct; 48(15):957-61. PubMed ID: 25889059
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials.
    Hyman DM; Solit DB; Arcila ME; Cheng DT; Sabbatini P; Baselga J; Berger MF; Ladanyi M
    Drug Discov Today; 2015 Dec; 20(12):1422-8. PubMed ID: 26320725
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clonal evolution and tumor-initiating cells: New dimensions in cancer patient treatment.
    Apostoli AJ; Ailles L
    Crit Rev Clin Lab Sci; 2016; 53(1):40-51. PubMed ID: 26397062
    [TBL] [Abstract][Full Text] [Related]  

  • 59. What have we learned from exceptional tumour responses?: Review and perspectives.
    Mehra N; Lorente D; de Bono JS
    Curr Opin Oncol; 2015 May; 27(3):267-75. PubMed ID: 25811347
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The translational challenges of precision oncology.
    Pich O; Bailey C; Watkins TBK; Zaccaria S; Jamal-Hanjani M; Swanton C
    Cancer Cell; 2022 May; 40(5):458-478. PubMed ID: 35487215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.